BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 22240942)

  • 21. CT-based interstitial brachytherapy in advanced gynecologic malignancies: outcomes from a single institution experience.
    D'Souza D; Wiebe E; Patil N; Sugimoto A; Prefontaine M; Aulakh S; Whiston F; Stitt L; Surry K
    Brachytherapy; 2014; 13(3):225-32. PubMed ID: 24613570
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Image Distortions on a Plastic Interstitial Computed Tomography/Magnetic Resonance Brachytherapy Applicator at 3 Tesla Magnetic Resonance Imaging and Their Dosimetric Impact.
    van Heerden LE; van Kesteren Z; Gurney-Champion OJ; Houweling AC; Koedooder K; Rasch CRN; Pieters BR; Bel A
    Int J Radiat Oncol Biol Phys; 2017 Nov; 99(3):710-718. PubMed ID: 29280466
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Image and laparoscopic guided interstitial brachytherapy for locally advanced primary or recurrent gynaecological cancer using the adaptive GEC ESTRO target concept.
    Fokdal L; Tanderup K; Nielsen SK; Christensen HK; Røhl L; Pedersen EM; Schønemann NK; Lindegaard JC
    Radiother Oncol; 2011 Sep; 100(3):473-9. PubMed ID: 21924784
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long term experience with 3D image guided brachytherapy and clinical outcome in cervical cancer patients.
    Ribeiro I; Janssen H; De Brabandere M; Nulens A; De Bal D; Vergote I; Van Limbergen E
    Radiother Oncol; 2016 Sep; 120(3):447-454. PubMed ID: 27157510
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inter-fractional variation of markers and applicators in single-implant high-dose-rate interstitial brachytherapy for gynecologic malignancies.
    Ostyn M; Burke AM; Fields E; Todor D
    Brachytherapy; 2021; 20(4):771-780. PubMed ID: 33994342
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 3D image-based adapted high-dose-rate brachytherapy in cervical cancer with and without interstitial needles: measurement of applicator shift between imaging and dose delivery.
    Karlsson L; Thunberg P; With A; Mordhorst LB; Persliden J
    J Contemp Brachytherapy; 2017 Feb; 9(1):52-58. PubMed ID: 28344604
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical impact of computed tomography-based image-guided brachytherapy for cervix cancer using the tandem-ring applicator - the Addenbrooke's experience.
    Tan LT; Coles CE; Hart C; Tait E
    Clin Oncol (R Coll Radiol); 2009 Apr; 21(3):175-82. PubMed ID: 19101130
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Image-guided interstitial high-dose-rate brachytherapy for locally recurrent uterine cervical cancer: A single-institution study.
    Umezawa R; Murakami N; Nakamura S; Wakita A; Okamoto H; Tsuchida K; Kashihara T; Kobayashi K; Harada K; Takahashi K; Inaba K; Ito Y; Igaki H; Masui K; Yoshida K; Jingu K; Tselis N; Itami J
    Brachytherapy; 2018; 17(2):368-376. PubMed ID: 29275869
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MR- versus CT-based high-dose-rate interstitial brachytherapy for vaginal recurrence of endometrial cancer.
    Kamran SC; Manuel MM; Catalano P; Cho L; Damato AL; Lee LJ; Schmidt EJ; Viswanathan AN
    Brachytherapy; 2017; 16(6):1159-1168. PubMed ID: 28823395
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Practical needle selection for Vienna-style applicators: improving therapeutic ratio in hybrid intracavitary-interstitial brachytherapy.
    Martin DA; Taunk NK; Anamalayil S; Mangal V; Marcel J; Hubley E
    J Contemp Brachytherapy; 2021 Oct; 13(5):533-540. PubMed ID: 34759978
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Three-dimensional conformal brachytherapy boost in locally recurrent or residual cervical carcinoma: does it impact clinical outcome?
    Bansal V; Kumar G; Bhutani R; Venkadamanickam G; Sharma SK; Sigamani AK; Shekhon R; Rawal SK
    J Obstet Gynaecol Res; 2013 Jan; 39(1):264-71. PubMed ID: 22640182
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CT-guided interstitial HDR-brachytherapy for recurrent glioblastoma multiforme: a 20-year single-institute experience.
    Chatzikonstantinou G; Zamboglou N; Archavlis E; Strouthos I; Zoga E; Milickovic N; Hilaris B; Baltas D; Rödel C; Tselis N
    Strahlenther Onkol; 2018 Dec; 194(12):1171-1179. PubMed ID: 30203110
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A dosimetric evaluation of using a single treatment plan for multiple treatment fractions within a given applicator insertion in gynecologic brachytherapy.
    Pinnaduwage DS; Cunha JA; Weinberg V; Krishnamurthy D; Nash M; Hsu IC; Pouliot J
    Brachytherapy; 2013; 12(5):487-94. PubMed ID: 23582467
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Historical overview and the current practice of intracavitary treatment of cervical and endometrial cancer in the Oncoradiology Center of Budapest].
    Sinkó D; Nemeskéri C; Pallinger Á; Weisz C; Naszály A; Landherr L
    Magy Onkol; 2015 Jun; 59(2):140-7. PubMed ID: 26035162
    [TBL] [Abstract][Full Text] [Related]  

  • 35. 3T multiparametric MRI-guided high-dose-rate combined intracavitary and interstitial adaptive brachytherapy for the treatment of cervical cancer with a novel split-ring applicator.
    Fredman E; Traughber B; Podder T; Colussi V; Zheng Y; Russo S; Herrmann K; Paspulati R; Waggoner S; Zanotti K; Nagel C; Nakayama J; Machtay M; Ellis R
    Brachytherapy; 2018; 17(2):334-344. PubMed ID: 29097137
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gold marker displacement due to needle insertion during HDR-brachytherapy for treatment of prostate cancer: a prospective cone beam computed tomography and kilovoltage on-board imaging (kV-OBI) study.
    Herrmann MK; Kertesz T; Gsänger T; Bloch E; Pollul G; Bouabdallaoui M; Strauss A; Herrmann M; Christiansen H; Wolff HA; Hess CF; Hille A
    Radiat Oncol; 2012 Feb; 7():24. PubMed ID: 22348595
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Improved treatment planning for the Syed-Neblett template using endorectal-coil magnetic resonance and intraoperative (laparotomy/laparoscopy) guidance: a new integrated technique for hysterectomized women with vaginal tumors.
    Corn BW; Lanciano RM; Rosenblum N; Schnall M; King S; Epperson R
    Gynecol Oncol; 1995 Feb; 56(2):255-61. PubMed ID: 7896194
    [TBL] [Abstract][Full Text] [Related]  

  • 38. HDRMC, an accelerated Monte Carlo dose calculator for high dose rate brachytherapy with CT-compatible applicators.
    Chibani O; C-M Ma C
    Med Phys; 2014 May; 41(5):051712. PubMed ID: 24784378
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reirradiation using high-dose-rate interstitial brachytherapy for locally recurrent cervical cancer: a single institutional experience.
    Mabuchi S; Takahashi R; Isohashi F; Yokoi T; Okazawa M; Sasano T; Maruoka S; Anzai M; Yoshioka Y; Ogawa K; Kimura T
    Int J Gynecol Cancer; 2014 Jan; 24(1):141-8. PubMed ID: 24362719
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interstitial brachytherapy using virtual planning and Doppler transrectal ultrasonography guidance for internal iliac lymph node metastasis.
    Yoshida K; Ueda M; Yamazaki H; Takenaka T; Yoshida M; Miyake S; Yoshida S; Koizumi M; Ban C; Tanaka E
    J Radiat Res; 2012; 53(1):154-8. PubMed ID: 22240939
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.